- Home
- EQIX vs BMY Comparison
EQIX vs BMY Comparison
Compare EQIX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQIX
- BMY
- Stock Information
- Founded
- EQIX 1998
- BMY 1887
- Country
- EQIX United States
- BMY United States
- Employees
- EQIX N/A
- BMY N/A
- Industry
- EQIX Real Estate Investment Trusts
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- EQIX Real Estate
- BMY Health Care
- Exchange
- EQIX Nasdaq
- BMY Nasdaq
- Market Cap
- EQIX 87.1B
- BMY 99.7B
- IPO Year
- EQIX 2000
- BMY N/A
- Fundamental
- Price
- EQIX $771.75
- BMY $44.23
- Analyst Decision
- EQIX Strong Buy
- BMY Hold
- Analyst Count
- EQIX 22
- BMY 15
- Target Price
- EQIX $954.90
- BMY $57.64
- AVG Volume (30 Days)
- EQIX 580.4K
- BMY 13.6M
- Earning Date
- EQIX 07-30-2025
- BMY 07-31-2025
- Dividend Yield
- EQIX 2.43%
- BMY 5.61%
- EPS Growth
- EQIX N/A
- BMY N/A
- EPS
- EQIX 10.22
- BMY 2.49
- Revenue
- EQIX $8,931,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- EQIX $7.73
- BMY N/A
- Revenue Next Year
- EQIX $7.94
- BMY N/A
- P/E Ratio
- EQIX $75.58
- BMY $17.79
- Revenue Growth
- EQIX 5.48
- BMY 2.57
- 52 Week Low
- EQIX $701.41
- BMY $42.96
- 52 Week High
- EQIX $994.03
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- EQIX 40.27
- BMY 37.26
- Support Level
- EQIX $785.37
- BMY $42.96
- Resistance Level
- EQIX $815.00
- BMY $47.26
- Average True Range (ATR)
- EQIX 15.93
- BMY 1.20
- MACD
- EQIX 3.51
- BMY -0.39
- Stochastic Oscillator
- EQIX 26.74
- BMY 20.09
About EQIX Equinix Inc. REIT
Equinix operates 260 data centers in 71 markets worldwide. It generates 44% of total revenue in the Americas, 35% in Europe, the Middle East, and Africa, and 21% in Asia-Pacific. The firm has more than 10,000 customers, including 2,100 network providers, that are dispersed over five verticals: cloud and IT services, content providers, network and mobile services, financial services, and enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from interconnection. Equinix operates as a real estate investment trust.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.